Polar Capital Holdings’s Edwards Lifesciences EW Stock Holding History

Polar Capital Holdings’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-317,886	Closed	-$24.7M	–	278
2025 Q3	$24.7M	Buy	317,886 +63,208	+25%	+$4.94M	0.12%	133
2025 Q2	$19.9M	Buy	+254,678	New	+$19M	0.1%	146
2023 Q1	–	Sell	-76,063	Closed	-$5.68M	–	306
2022 Q4	$5.68M	Sell	76,063 -21,505	-22%	-$1.66M	0.05%	232
2022 Q3	$8.06K	Buy	97,568 +2,954	+3%	+$284K	0.05%	213
2022 Q2	$9K	Sell	94,614 -2,065	-2%	-$214K	0.05%	203
2022 Q1	$11.4K	Buy	96,679 +2,096	+2%	+$235K	0.05%	218
2021 Q4	$12.3K	Buy	94,583 +9,338	+11%	+$1.09M	0.05%	216
2021 Q3	$9.65K	Buy	85,245 +3,678	+5%	+$420K	0.04%	236
2021 Q2	$8.45K	Buy	+81,567	New	+$7.69M	0.04%	243

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Polar Capital Holdings's EW Position: Q4 2025 in Review

Polar Capital Holdings sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 317,886 shares — an estimated $24.7M sold.

Polar Capital Holdings first reported a position in EW in Q2 2021 and held it in 9 quarters. The position peaked at $24.7M in Q3 2025. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

Polar Capital Holdings reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
Polar Capital Holdings sold 317,886 Edwards Lifesciences shares in Q4 2025, an estimated $24.7M.
Polar Capital Holdings first reported a position in Edwards Lifesciences in Q2 2021 and held it in 9 quarters.
Polar Capital Holdings's Edwards Lifesciences position peaked at $24.7M in Q3 2025.
1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Polar Capital Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.